Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit

Vaccine

Volumn 16, Issue 17, 1998, Pages 1620-1626

  Isaka, Masanori ^a   Yasuda, Yoko ^a   Kozuka, Satoshi ^a   Miura, Yutaka ^a   Taniguchi, Tooru ^a   Matano, Keiko ^a   Goto, Norihisa ^b   Tochikubo, Kunio ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Aluminium adsorbed tetanus toxoid; Aluminium non adsorbed tetanus toxoid; Intranasal immunization; Recombinant cholera toxin B subunit (rCTB)

Indexed keywords

CHOLERA TOXIN B SUBUNIT; IMMUNOGLOBULIN G; RECOMBINANT VACCINE; TETANUS TOXOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; INTRANASAL DRUG ADMINISTRATION; MOUSE; MUCOSA; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, INTRANASAL; ADSORPTION; ALUMINUM; ANIMALS; ANTIBODIES, BACTERIAL; CHOLERA TOXIN; FEMALE; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; TETANUS TOXOID; VACCINES, SYNTHETIC;

EID: 0032192572     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00066-8     Document Type: Article

References (41)

1. 1 Elson, C.O. and Ealding, W. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. Journal of Immunology 1984, 133, 2892-2897.
2. 2 Lycke, N. and Holmgren, J. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 1986, 59, 301-308.
3. 3 Nedrud, J.G., Liang, X., Hague, N. and Lamm, M.E. Combined oral/nasal immunization protects mice from Sendai virus infection. Journal of Immunology 1987, 139, 3484-3492.
4. 4 Liang, X., Lamm, M.E. and Nedrud, J.G. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus. Journal of Immunology 1988, 141, 1495-1501.
5. 5 Wilson, A.D., Clarke, C.J. and Stokes, C.R. Whole cholera toxin and B subunit act synergistically as an adjuvant for the mucosal immune response of mice to keyhole limpet haemocyanin. Scandinavian Journal of Immunology 1990, 31, 443-451.
6. 6 Vajdy, M. and Lycke, N.Y. Cholera toxin adjuvant promotes long-term immunological memory in the gut mucosa to unrelated immunogens after oral immunization. Immunology 1992, 75, 488-492.
7. 7 Tamura, S.-I., Samegai, Y., Kurata, H., Nagamine, T., Aizawa, C. and Kurata, T. Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit. Vaccine 1988, 6, 409-413.
8. 8 Lee, A. and Chen, M. Successful immunization against gastric infection with Helicobacter species: use of a cholera toxin B-subunit-whole-cell vaccine. Infection and Immunity 1994, 62, 3594-3597.
9. 9 Vadolas, J., Davies, J.K., Wright, P.J. and Strugnell, R.A. Intranasal immunization with liposomes induces strong mucosal immune responses in mice. European Journal of Immunology 1995, 25, 969-975.
10. 10 Hathaway, L.J., Partidos, C.D., Vohra, P. and Steward, M.W. Induction of systemic immune responses to measles virus synthetic peptides administered intranasally. Vaccine 1995, 13, 1495-1500.
11. 11 Czerkinsky, C., Russell, M.W., Lycke, N., Lindblad, M. and Holmgren, J. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infection and Immunity 1989, 57, 1072-1077.
12. 12 Tamura, S.-I., Yamanaka, A. and Shimohara, M. et al. Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. Vaccine 1994, 12, 419-426.
13. 13 Ichikawa, Y., Yamagata, H., Tochikubo, K. and Udaka, S. Very efficient extracellular production of cholera toxin B subunit using Bacillus brevis. FEMS Microbiology Letters 1993, 111, 219-224.
14. 14 Tochikubo, K., Isaka, M. and Yasuda, Y. et al. Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin. Vaccine 1998, 16, 150-155.
15. 15 Stok, W., Van der Heijden, P.J. and Bianchi, A.T.J. Conversion of orally induced suppression of the mucosal immune response to ovalbumin into stimulation by conjugating ovalbumin to cholera toxin or its B subunit. Vaccine 1994, 12, 521-526.
16. 16 de Geus, B., Dol-Bosman, M., Scholten, J.W., Stok, W. and Bianchi, A. A comparison of natural and recombinant cholera toxin B subunit as stimulatory factors in intranasal immunization. Vaccine 1997, 15, 1110-1113.
17. 17 Tamura, S.-I., Asanuma, H. and Tomita, T. et al. Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine. Vaccine 1994, 12, 1083-1089.
18. 18 Hashigucci, K., Ogawa, H. and Ishidate, T. et al. Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin. Vaccine 1996, 14, 113-119.
19. 19 Aggerbeck, H., Gizurarson, S., Wantzin, J. and Heron, I. Intranasal booster vaccination against diphtheria and tetanus in man. Vaccine 1997, 15, 307-316.
20. 20 Jackson, R.J., Fujihashi, K., Xu-Amano, J., Kiyono, H., Elson, C.O. and McGhee, J.R. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infection and Immunity 1993, 61, 4272-4279.
21. 21 Butler, N.R., Voyce, M.A., Burland, W.L. and Hilton, M.L. Advantages of aluminium hydroxide adsorbed combined diphtheria, tetanus, and pertussis vaccines for the immunization of infants. British Medical Journal 1969, 1, 663-666.
22. 22 Frost, L., Johansen, P., Pedersen, S., Veien, N., Østergaard, P.A. and Nielsen, M.H. Persistent subcutaneous nodules in children hyposensitized with aluminium-containing allergen extracts. Allergy 1985, 40, 368-372.
23. 23 White, R.G., Coons, A.H. and Connolly, J.M. Studies on antibody production. III. The alum granuloma. Journal of Experimental Medicine 1955, 102, 73-82.
24. 24 Erdohazi, M. and Newman, R.L. Aluminium hydroxide granuloma. British Medical Journal 1971, 3, 621-623.
25. 25 Goto, N. and Akama, K. Histopathological studies of reactions in mice injected with aluminum-adsorbed tetanus toxoid. Microbiology and Immunology 1982, 26, 1121-1132.
26. 26 Goto, N. and Akama, K. Local histopathological reactions to aluminum-adsorbed tetanus toxoid. Naturwissenschaften 1984, 71, 427-428.
27. 27 Goto, N., Kato, H. and Maeyama, J. et al. Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminium hydroxide with different physical properties. Vaccine 1997, 15, 1364-1371.
28. 28 Vassilev, T.L. Aluminium phosphate but not calcium phosphate stimulates the specific IgE response in guinea pigs to tetanus toxoid. Allergy 1978, 33, 155-159.
29. 29 Cogné, M., Ballet. J.J., Schmitt, C. and Bizzini, B. Total and IgE antibody levels following booster immunization with aluminum absorbed and nonabsorbed tetanus toxoid in humans. Annals of Allergy 1985, 54, 148-151.
30. 30 Veien, N.K., Hattel, T., Justesen, O. and Nørholm, A. Aluminium allergy. Contact Dermatitis 1986, 15, 295-297.
31. 31 Alfrey, A.C., Le Gendre, G.R. and Kaehny, W.D. The dialysis encephalopathy syndrome: possible aluminum intoxication. New England Journal of Medicine 1976, 294, 184-188.
32. 32 Crapper, D.R., Quittkat, S., Krishnan, S.S., Dalton, A.J. and De Boni, U. Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy, and experimental aluminum encephalopathy. Acta Neuropathologica (Berlin) 1980, 50, 19-24.
33. 33 Perl, D.P. and Pendlebury, W.W. Aluminum neurotoxicity - potential role in the pathogenesis of neurofibrillary tangle formation. Canadian Journal of Neurological Sciences 1986, 13, 441-445.
34. 34 McLachlan, D.R.C., Lukiw, W.J. and Kruck, T.P.A. New evidence for an active role of aluminum in Alzheimer's disease. Canadian Journal of Neurological Sciences 1989, 16, 490-497.
35. 35 Mosmann, T.R. and Coffman, R.L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annual Review of Immunology 1989, 7, 145-173.
36. 36 Street, N.E. and Mosmann, T.R. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB Journal 1991, 5, 171-177.
37. 37 Yamamoto, S., Kiyono, H. and Yamamoto, M. et al. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proceedings of the National Academy of Sciences USA 1997, 94, 5267-5272.
38. 38 Marinaro, M., Staats, H.F. and Hiroi, T. et al. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. Journal of Immunology 1995, 155, 4621-4629.
39. 39 Takahashi, I., Marinaro, M. and Kiyono, H. et al. Mechanisms for mucosal immuogenicity and adjuvancy of Escherichia coli labile enterotoxin. Journal of Infectious Diseases 1996, 173, 627-635.
40. 40 Mirchamsy, H., Hamedi, M., Fateh, G. and Sassani, A. Oral immunization against diphtheria and tetanus infections by fluid diphtheria and tetanus toxoids. Vaccine 1994, 12, 1167-1172.
41. 41 Norton, P.M., Wells, J.M., Brown, H.W.G., Macpherson, A.M. and Le Page, R.W.F. Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C. Vaccine 1997, 15, 616-619.